Close Menu

gastrointestinal cancer

The partners will identify patients with gastrointestinal or endometrial cancers who may benefit from immune checkpoint inhibitor therapy using Biotype's technology.

Researchers associated with the Cancer Genome Atlas (TCGA) Research Network will publish more than 25 papers this week to discuss findings from the initiative.

The firm's Guardant360 assay will be used first to test patients for ERBB2 mutations, then guide patients to a variety of treatment arms.

The partners aim to identify master regulators in the molecular networks of GIST patients that can serve as drug targets for existing treatments.

This Week in Science

In Science this week: immunogenic mutations in GI cancers, and more.

The research may lay the groundwork for a noninvasive test for GI or other types of cancer without prior knowledge of which organ is affected.

The agreement expands the partners' alliance to include additional diseases within the gastrointestinal tract.

In GIST tumors lacking genetic mutations, researchers uncover an epimutation affecting a gene promoter.

Pages

Researchers trace DNA on a clay pipe found at a former slave site to a population that lives in what is now Sierra Leone, the Washington Post reports.

Two researchers report on their genetic analysis of samples from a shawl thought to belong to a victim of Jack the Ripper, ScienceInsider reports.

Japan is to release rules governing some gene-edited food, according to NHK World.

In PLOS this week: computational strategy for improving gene set analysis testing, miRNAs linked to sleep apnea, and more.